Description
What does it really take to bring a NeuroTech medical device from idea to market? Join NAMSA and a panel of renowned Key Opinion Leaders – Dr. Brian Litt (neurologist and bioengineering pioneer) and Dr. James Kryzanski (neurosurgeon and medical device entrepreneur) – as we explore the hottest trends in NeuroTech medical device development, regulatory and clinical strategies in getting to market and being successful, and what payers and clinicians expect from clinical evidence.
Key Learning Objectives:
- Understand the hottest trends in NeuroTech in 2026
- Understand what companies need to succeed: Addressing the unmet need and overcoming the challenges of regulatory authorization, reimbursement coverage, and clinical adoption
- Understand how to design preclinical and clinical studies that generate bench, animal, and human evidence that not only satisfy regulatory requirements but also prove value for payers and clinicians
- Understand how NeuroTech is uniquely positioned to advance and take advantage of decentralized clinical trials
Speakers
James Kryzanski, MD
Neurosurgeon and Entrepreneur
Dr. Kryzanski is a board-certified neurosurgeon at Tufts Medical Center, where he serves as Director of the Epilepsy Surgery Program and Co-Director of the Spine Surgery Program. He is a Clinical Associate Professor at Tufts Medical School with extensive experience in awake spinal surgery, minimally invasive techniques, and epilepsy treatment. He is co-investigator on several NIH-funded studies totaling over $4 million and holds multiple U.S. patents on subdural electrode technologies.
Brian Litt, MD
Neurologist, Innovator and Bioengineer
Dr. Litt is a world-renowned neurologist, bioengineer, and innovator at the University of Pennsylvania. He is recognized for pioneering work in epilepsy, neuroengineering, and medical device development, bridging clinical care, engineering, and translational research. He is co-founder and advisor for multiple medical device startups, including NeuroVista, MC10, Blackfynn, EpilepsyCo, and others. He is also a Principal Investigator on several NIH-funded projects for implantable devices, brain-computer interfaces, and AI-driven diagnostics.
Chief Medical Officer at NAMSA
As a Board-Certified Cardiothoracic Surgeon, Dr. Saltman has more than 25 years’ experience in the management of complex patients with multiple comorbidities. He also worked for 12 years as a Medical Officer at the U.S. FDA Center for Devices and Radiological Health, where he gained a deep understanding of the requirements for successful medical device introductions, as well as quality systems, compliance and benefit-risk evaluations. Before joining NAMSA, Dr. Saltman earned industry experience as the first Chief Medical and Regulatory Officer for two medical device organizations, during which he successfully brought three AI-powered devices through R&D, clinical validation, regulatory approval and market introduction.
*By registering for this event, you are providing NAMSA consent to contact you directly regarding NAMSA’s services. The information you are providing will be processed by NAMSA to better understand your product needs and interests. At any time, you can submit a request to withdraw your consent for the use of information provided by you by contacting us at: communications@namsa.com. For additional information, please visit our Privacy Policy or contact us at privacy@namsa.com.
NAMSA uses a third-party provider, GoToWebinar, to host NAMSA webinars. For information related to GoToWebinar’s privacy policy and utilization of information, please contact GoToWebinar directly.
This is a free educational webinar.
Register Now
